Table 1.
Factors determining disease risk in AML.
Clinical Variables | Molecular variables | Dynamic variables |
---|---|---|
• Age | • Cytogenetic | • Response to course 1 by morphology |
• Gender | • Next generation sequencing of genes e.g. FLT3, NPM1, RUNX1, ASXL1, TP53 | • Response to treatment by MRD |
• Presenting white cell count | ||
• Primary versus secondary disease | ||
• Performance status |